OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001138608

BLOOMIOS, INC.

BLOOMIOS, INC. (CIK 0001138608, EIN 87-4696476) reported revenue of $6.08 million ($6,077,080) for FY2022 (2022-01-01 to 2022-12-31) and net income of -$13.77 million (-$13,774,165) for FY2022 (2022-01-01 to 2022-12-31), as filed in its 10-K filed 2023-04-17 (accession 0001477932-23-002660).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001138608
EIN87-4696476
SIC industry code2833 Medicinal Chemicals & Botanical Products
Fiscal year endDecember 31
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
Olympus entity IDorg_20f4kp9tpja6mvq1zxvrdjqw1c
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$6,077,080FY20222022-01-01 to 2022-12-3110-K2023-04-170001477932-23-002660Revenues
Net income-$13,774,165FY20222022-01-01 to 2022-12-3110-K2023-04-170001477932-23-002660NetIncomeLoss
Total assets$26,010,888FY2022as of 2022-12-3110-K2023-04-170001477932-23-002660Assets
Total liabilities$27,331,835FY2022as of 2022-12-3110-K2023-04-170001477932-23-002660Liabilities
Stockholders' equity-$1,320,947FY2022as of 2022-12-3110-K2023-04-170001477932-23-002660StockholdersEquity
Operating cash flow-$6,325,707FY20222022-01-01 to 2022-12-3110-K2023-04-170001477932-23-002660NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$0.09 per shareFY20202020-01-01 to 2020-12-3110-K/A2021-07-140001477932-21-004612EarningsPerShareBasicAndDiluted
Shares outstanding29,949,538 sharesFY2022as of 2023-04-1210-K2023-04-170001477932-23-002660EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2013-2022, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20222022-01-01 to 2022-12-31$6,077,08010-K2023-04-170001477932-23-002660
RevenueFY20212021-01-01 to 2021-12-31$8,491,65110-K2023-04-170001477932-23-002660
RevenueFY20202020-01-01 to 2020-12-31$1,316,30410-K2022-04-150001477932-22-002409
RevenueFY20202019-02-01 to 2020-01-31$010-K2020-07-090001477932-20-003851
Net incomeFY20222022-01-01 to 2022-12-31-$13,774,16510-K2023-04-170001477932-23-002660
Net incomeFY20212021-01-01 to 2021-12-31-$2,011,32810-K2023-04-170001477932-23-002660
Net incomeFY20202020-01-01 to 2020-12-31-$1,170,66610-K2022-04-150001477932-22-002409
Net incomeFY20202019-02-01 to 2020-01-31-$16,86310-K2020-07-090001477932-20-003851

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2023-11-202023-09-300001477932-23-008672blms_10q.htm
10-Q2023-08-212023-06-300001477932-23-006291blms_10q.htm
10-Q2023-05-182023-03-310001477932-23-003735blms_10q.htm
10-K2023-04-172022-12-310001477932-23-002660blms_10k.htm
10-Q2022-11-212022-09-300001477932-22-008807blms_10q.htm
10-K/A2022-11-142021-12-310001477932-22-008334blms_10ka.htm
10-Q2022-08-222022-06-300001477932-22-006356blms_10q.htm
10-Q2022-05-132022-03-310001477932-22-003248xlrm_10q.htm
10-K2022-04-152021-12-310001477932-22-002409xlrm_10k.htm
10-Q2021-11-152021-09-300001477932-21-008259xlrm_10q.htm
10-Q2021-08-192021-06-300001477932-21-005758xlrm_10q.htm
10-K/A2021-07-142020-12-310001477932-21-004612xlrm_10ka.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001138608published by the sourcedata.sec.gov/submissions/CIK0001138608.json2026-10-21
Employer Identification Number (EIN) · US-EIN87-4696476published by the sourcedata.sec.gov/submissions/CIK0001138608.json2026-10-21

Former names

NameFromTo
XLR MEDICAL CORP.2004-09-172021-04-15
RELAY MINES LTD2001-05-012004-08-30

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001138608.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001138608.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001138608" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001138608/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001138608/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1138608"}

On SEC EDGAR

About this data